Article citationsMore>>

B. K. Madras, Z. Xie, Z. Lin, A. Jassen, H. Panas, L. Lynch, R. Johnson, E. Livni, T. J. Spencer, A. A. Bonab, G. M. Miller and A. J. Fischman, “Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro,” Journal of Pharmacology and Experimental Therapeutics, Vol. 319, No. 2, 2006, pp. 561-569. doi:10.1124/jpet.106.106583

has been cited by the following article:

• TITLE: Ventricular Tachycardia during Treatment with Modafinil for Narcolepsy: A Case Report

  AUTHORS: Heleen Binnenmars, Herman H. D. Idzerda, Hanno L. Tan, Gerard C. M. Linssen

  KEYWORDS: Modafinil; Narcolepsy; Ventricular Tachycardia

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.3 No.6, November 22, 2012

  ABSTRACT: Pharmacological treatment of narcolepsy is complex. We reported a case of recurrent episodes of polymorphic ventricular tachycardia attributed to the use of modafinil, a recently approved wake-promoting agent for narcolepsy and shift work sleep disorder. Modafinil is also approved as adjunctive treatment of obstructive sleep apnea/hypopnea syndrome. While the exact mechanism of action for modafinil is not known, central dopamine receptors seem to play an essential role. Adverse influences on the electrocardiogram (ECG) or drug-related cardiac arrhythmias are rarely reported, but are considered as clinically important.